A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism
Trial ID or NCT#
Status
Purpose
The purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).
Official Title
A Center Based Randomized Controlled Trial of Pivotal Response Treatment for Preschoolers With Autism
Eligibility Criteria
- - Diagnosis of Autism Spectrum Disorder (ASD) based on clinical interview and Diagnostic and Statistical Manual, 5th edition (DSM-5) and confirmed using the Autism Diagnostic Interview Revised (ADI-R) and Autism Diagnostic Observation Schedule, 2nd edition (ADOS-2) or Childhood Autism Rating Scale (CARS-2); Diagnostic and Statistical Manual, 5th edition (DSM-5), and expert clinical opinion - Boys and girls between 2 years and 3 years and 11 months - Ability to participate in the testing procedures to the extent that valid standard scores can be obtained - Stable treatment (e.g., applied behavior analysis (ABA), speech therapy, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation - Developmentally delayed with Mullen Scales of Early Learning (MSEL) or Developmental Profile (DP-4) composite score below 85 (1 Standard Deviation below the mean) - Availability of at least one English-speaking parent who can consistently participate in parent training and research measures.
- - Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.) - Presence of active medical problem (e.g., unstable seizure disorder or heart disease) - Child primary language other than English - Previous adequate trial of Pivotal Response Treatment - More than 15 hours per week of in-home applied behavior analysis (ABA).
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Madeleine Clark, BS
650-736-1235
View on ClinicalTrials.gov